Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets
Status:
Recruiting
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
To Evaluate the Safety, Tolerability and Pharmacokinetics of GST-HG131 Tablets in
Single-center, Randomized, Double-blind, Placebo-controlled Multiple-dose, Single-dose,
Multiple-dose Phase Ia Clinical Trials in Healthy Subjects